Dihydrooroidin was converted to the marine natural product oroidin in 75 % overall yield by chlorination of the 2-aminoimidazole unit in DMF, followed by dehydrochlorination. The natural product ugibohlin was synthesized for the first time by ring opening of dibromoisophakellin, which was obtained in a quantitative manner by heating the free base of dibromophakellin in neutral aqueous solution.
Oroidin (4, Scheme 1) serves as parent compound of the marine pyrrole-imidazole alkaloids [1] and was identified as the fish feeding deterrent principle of sponges of the genus Agelas [2] . Recently, oroidin (4) became a lead structure against bacterial biofilm formation [3] . Several total syntheses of oroidin (4) have been reported [4, 5] , all of which contain steps with only moderate yields. Since large quantities of oroidin (4) are needed for research on the chemistry of pyrroleimidazole alkaloids, we decided to reinvestigate the conversion of dihydrooroidin (1) to oroidin (4) .
Horne and coworkers had achieved the oxidative dimethoxylation of 1 (75 %) by treatment with Br 2 /KOtBu/MeOH, followed by thermal elimination of two molecules of MeOH (Scheme 1) [5] . However, a mixture of oroidin (4, 48 %) and dihydrodispacamide A (5, 30 %) had been obtained. Avoiding the formation of 5 could double the overall yield of that final step. Ideally, a halogen substituent would have to be installed at C-12 of dihydrooroidin (1), followed by dehydrohalogenation. Acidic conditions should be avoided, because it is known that when dihydrooroidin (1) is treated with NBS/TFA, spirocyclization occurs [6] , as it does with Br 2 /HOAc [7] . In the absence of an internal amide nucleophile, bromination of the 2-aminoimidazole would be possible in TFA [8] .
The starting material dihydrooroidin (1) was synthesized as the hydrochloride following the Büchi/Horne protocol [5, 7, 8] and was reacted with NCS/MeOH to 0932-0776 / 09 / 1100-1612 $ 06.00 c 2009 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com the dimethoxylated product 2 without participation of the internal amide nucleophile (Scheme 1). This indicated that spirocyclization does not take place under neutral conditions. Earlier, Horne and coworkers had successfully applied the same conditions to the free amine lacking the pyrrolylcarbonyl unit of dihydrooroidin (2) [5] . It remained to be answered whether spirocyclization of 1 would occur in neutral non-nucleophilic solvents.
We were pleased that dihydrooroidin hydrochloride (1-HCl) was converted to 12-chloro-8,9-dihydrooroidin (3) on reaction with NCS (1 eq.) in DMF in a yield of 81 % within 1 h at r. t. Compound 3 proved to be stable at r. t., and it was isolated as the free base after chromatography employing an ammonia-containing mobile phase. In the 13 C NMR spectrum ([D 6 ]DMSO) of 3, the chlorinated carbon appears at δ = 119 ppm, as determined by HMBC analysis. Spirocyclization did not occur. The reaction of 2-aminoimidazolium chlorides with NCS under neutral conditions probably does not involve a dication. Simultaneous transfer of one of the 2-aminoimidazolium protons to the succinimide oxygen is likely.
On heating of 3 in DMF to 100 • C for 1 h, clean formation of oroidin (4) occurred (85 %). Below 100 • C, elimination of HCl was sluggish, whereas at higher temperatures, decomposition occurred. Dihydrodispacamide A (5) was not formed as a byproduct. The sequence can be carried out without workup Scheme 1. Improved protocol for the conversion of dihydrooroidin hydrochloride (1-HCl) to the key pyrroleimidazole alkaloid oroidin (4). of compound 3 in one step and 75 % yield. With NBS (1 eq.) in DMF, dihydrooroidin hydrochloride (1-HCl) afforded the bromo analog, which was more difficult to purify than 3.
With dihydrooroidin (1) in hands, we also cyclized the compound to rac-dibromophakellin (6) following the Büchi/Horne procedure [6, 7] in order to study the isomerization of 6 to the thermodynamically more stable natural product dibromoisophakellin (7, Scheme 2). Dibromophakellin [11] and dibromoisophakellin [9, 12] occur in Agelas sponges in both enantiomeric forms. For a detailed NMR analysis of 6, 7, and also 4, see reference [10] . It was known that 6 can be converted to 7 by treatment with K 2 CO 3 /PhCl in about 50 % yield [6] . We found that refluxing the free base 6 under neutral conditions in water for 48 h affords 7 in nearly quantitative yield. Interestingly, dibromophakellin-HCl (6-HCl) did not react under the same conditions. Under protonating conditions, dibromophakellin (6) undergoes opening of ring D at the N,N-ketal moiety forming a tricyclic vinylguanidine [11] . In our hands, treatment of its isomer rac-dibromoisophakellin (7) with 6 M aqueous HCl at r. t. afforded the natural product ugibohlin (8, 88 %), originally isolated from the marine sponge Axinella carteri [12] . UgibohlinHCl (8-HCl) proved to be better soluble in [D 6 ]DMSO than the HCO 2 H adduct first obtained after RP chromatography (Scheme 2). The natural product Nmethyldibromoisophakellin (rac-9) [13] was obtained by treatment of rac-7 with NaH/MeI in DMF (78 %). Conversion of 9 to the hydrochloride had to be carried out under very diluted conditions [1 N aqueous HCl/MeOH (1 : 500)], because opening of ring D occurred when employing higher concentrations of acid.
Cleavage of ring B by heterolysis of the N,N-acetal of rac-dibromophakellin (6) with electron shift to the pyrrole carboxamide requires that the guanidine moi-Scheme 2. Conversion of rac-dibromophakellin (6) to ugibohlin hydrochloride (8-HCl) and rac-N-methyldibromoisophakellin hydrochloride (9-HCl).
ety of ring D is not protonated. Otherwise, two positive charges would initially be located at the aminoimidazoline ring. Probably for that reason, the hydrochloride 6-HCl does not open on the pyrrole side, whereas the neutral free base 6 does. Cleavage of ring D by heterolysis of the N,N-ketal of 6 or 7 will shift the electrons of the C-N bond to the guanidine unit with formation of an acyliminium ion. Protonating reaction conditions are required, whereas reaction even of the hydrochloride salt 6-HCl under neutral conditions did not occur.
In summary, the conversion of dihydrooroidin (1) to oroidin (4) is now possible in 75 % overall yield, making the pathway via 3 the most practical in providing large quantities of the key metabolite oroidin (4). The conversion of dibromophakellin (6) to dibromoisophakellin (7) is now a quantitative process in water. The natural products ugibohlin (8) and Nmethyldibromoisophakellin (9) have been synthesized for the first time.
Experimental Section
General NMR spectra were taken with Bruker DRX-400 (400.1 MHz for 1 H, 100.6 MHz for 13 C) and Bruker AV II-600 (600.1 MHz for 1 H; 150.9 MHz for 13 C) instruments, referenced to the solvent signal or TMS. All measurements were carried out at 300 K. Mass spectra were obtained with a
Chlorodihydrooroidin (3)
At 0 • C, N-chlorosuccinimide (30.5 mg, 0.22 mmol) was added to a solution of dihydrooroidin-HCl (1-HCl, 100 mg, 0.22 mmol, [5] ) in DMF (10 mL). The mixture was stirred at r. 
Oroidin-HCO 2 H (4-HCO 2 H)
A solution of N-chlorosuccinimide (30.5 mg, 0.22 mmol) and dihydrooroidin-HCl (1-HCl, 100 mg, 0.22 mmol, [5] ) in DMF (10 mL) was stirred at r. t. for 1 h and then at 100 
Dibromophakellin (6) and dibromophakellin-HCl (6-HCl)
NBS (35.6 mg, 0.2 mmol) was added to a solution of dihydrooroidin-HCl (1-HCl, 42.8 mg, 0.1 mmol, [5] ) in TFA (1 mL) in one portion, and the reaction was stirred for 5 min. The solvent was evaporated under reduced pressure, and the resulting residue was quenched with THF/Et 3 N (1 : 1, 2 mL). Evaporation of the solvent afforded an oil, which was diluted with acetone (0.5 mL) and triturated with Et 2 O (3 mL). After filtration, the solid was purified by column chromatography [silica, CHCl 3 /MeOH/25 % aqueous NH 3 
Dibromoisophakellin-HCl (7-HCl)
Dibromophakellin (6, 38.9 mg, 0.1 mmol) was suspended in 10 mL H 2 O and refluxed for 48 h. After evaporation of H 2 O, the residue was washed with Et 2 O (3 × 5 mL), acetone (1 × 5 mL), and recrystallized from water. A solution of dibromoisophakellin (7) in MeOH (10 mL) was treated with 12 N aqueous HCl (10 µL) to form dibromoisophakellinHCl (7-HCl) after evaporation of the solvent (40.8 mg, 0.09 mmol, 96 %). Reversed-phase column chromatography of 
N-Methyldibromoisophakellin-HCl (9-HCl)
At 0 • C, methyl iodide (3.2 µL, 0.5 mmol) and NaH (60 % dispersion in mineral oil, 2.1 mg, 0.5 mmol) were added to a solution of dibromoisophakellin (7, 20 mg, 0.5 mmol) in DMF (2 mL). After 2 h at r. t., saturated aqueous NaHCO 3 (5 mL) and n-BuOH (5 mL) were added. The aqueous phase was washed twice with n-BuOH, and the combined organic phases were dried over MgSO 4 
